A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone

Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 1

Abstract

.

Authors and Affiliations

Erdi Şahin

Keywords

Related Articles

Isolated Third, Fourth, and Sixth Cranial Nerve Palsies in the Turkish Population: Etiologic Factors and Clinical Course

Objective: To determine the etiologic factors and clinical profile of isolated third, fourth, and sixth nerve palsies in neuro-ophthalmology outpatient clinics of two different reference centers. Materials and Methods:...

Nutritional Approach and Treatment in Patients with Stroke, An Expert Opinion for Turkey

Cerebrovascular diseases comprise the most common category of inpatient cases taken care of by neurologists. Dysphagia and malnutrition are not rare after stroke. It is strongly recommended for neurologists to screen and...

Major Vascular Neurocognitive Disorder: A Reappraisal to Vascular Dementia

Major vascular neurocognitive disorder (NCD) is the second leading form of dementia after Alzheimer’s disease, accounting for 17-20% of all dementias. Vascular NCD is a progressive disease caused by reduced cerebral bloo...

The Assesment of Efficacy of Traditional and Complementary Medicine Practices in Neurology

Traditional, complementary, and alternative medicine practices are used in the prevention, diagnosis, and treatment of a wide variety of diseases in the world. Such practices in Turkey are regulated by the “Regulation of...

Download PDF file
  • EP ID EP277538
  • DOI 10.4274/tnd.90698
  • Views 81
  • Downloads 0

How To Cite

Erdi Şahin (2018). A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone. UNKNOWN, 24(1), 105-106. https://europub.co.uk/articles/-A-277538